NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

SERA

Sera Prognostics Inc

Jul 03 • 04:00PM ET

2.49

Dollar change +0.04
Percentage change 1.63	%

Healthcare • Medical Devices • USA • NASD

Peers: ILMN NTRA GH BIO EXAS ONC CDNA QDEL RCKT VERU

| Held by: VTI VXF VTWO IWC VTWG AVSC VTHR MSSM

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.94	Insider Own	38.27%	Shs Outstand	36.70M	Perf Week	25.76%
Market Cap	93.81M	Forward P/E	-	EPS next Y	-0.94	Insider Trans	-1.85%	Shs Float	23.26M	Perf Month	30.37%
Enterprise Value	48.18M	PEG	-	EPS next Q	-0.23	Inst Own	49.31%	Short Float	3.76%	Perf Quarter	-27.83%
Income	-32.99M	P/S	781.75	EPS this Y	10.10%	Inst Trans	29.11%	Short Ratio	2.26	Perf Half Y	-70.14%
Sales	0.12M	P/B	0.99	EPS next Y	-5.62%	ROA	-31.71%	Short Interest	0.87M	Perf YTD	-69.41%
Book/sh	2.52	P/C	2.03	EPS next 5Y	2.77%	ROE	-41.36%	52W High	9.13 -72.73%	Perf Year	-58.77%
Cash/sh	1.23	P/FCF	-	EPS past 3/5Y	4.46% -13.01%	ROIC	-34.80%	52W Low	1.37 81.75%	Perf 3Y	15.28%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-2.08% 16.42%	Gross Margin	-798.26%	Volatility	33.43% 16.55%	Perf 5Y	-
Dividend TTM	-	EV/Sales	401.50	EPS Y/Y TTM	12.77%	Oper. Margin	-31989.57%	ATR (14)	0.36	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	2.02	Sales Y/Y TTM	-44.17%	Profit Margin	-28685.22%	RSI (14)	53.90	Recom	1.67
Dividend Gr. 3/5Y	- -	Current Ratio	2.02	EPS Q/Q	22.36%	SMA20	22.00%	Beta	1.00	Target Price	2.75
Payout	-	Debt/Eq	0.01	Sales Q/Q	-	SMA50	12.26%	Rel Volume	0.21	Prev Close	2.45
Employees	64	LT Debt/Eq	0.00	Earnings	May 07 AMC	SMA200	-51.24%	Avg Volume	386.97K	Price	2.49
IPO	Jul 15, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	14.89% -62.00%	Trades		Volume	80,123	Change	1.63%

Date	Action	Analyst	Rating Change	Price Target Change
Mar-30-22	Downgrade	Citigroup	Buy → Neutral	$18 → $4
Nov-19-21	Initiated	Oppenheimer	Outperform	$19
Oct-15-21	Resumed	Cowen	Outperform

May-29-25 09:35AM	After Plunging 43.9% in 4 Weeks, Here's Why the Trend Might Reverse for Sera Prognostics (SERA) (Zacks)
08:30AM	SERA PROGNOSTICS TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES (PR Newswire)
May-14-25 04:05PM	SERA PROGNOSTICS TO PRESENT AT RBC GLOBAL HEALTHCARE CONFERENCE (PR Newswire) +6.00%
May-13-25 09:35AM	Down -30.54% in 4 Weeks, Here's Why Sera Prognostics (SERA) Looks Ripe for a Turnaround (Zacks)
May-08-25 04:40PM	SERA PROGNOSTICS APPOINTS LEE ANDERSON AS CHIEF COMMERCIAL OFFICER (PR Newswire) -11.67%
03:36AM	Loading…
03:36AM	Sera Prognostics Inc (SERA) Q1 2025 Earnings Call Highlights: Revenue Growth and Strategic ... (GuruFocus.com)
May-07-25 05:55PM	Sera Prognostics, Inc. (SERA) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:05PM	SERA PROGNOSTICS REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS (PR Newswire)
Apr-24-25 08:30AM	Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2025 Financial Results on May 7, 2025 (PR Newswire)
Apr-15-25 01:54AM	Sera Prognostics: Initiating With Hold, Potential Of PreTRM Test, But Uncertain Commercial Timeline (Seeking Alpha)
Mar-19-25 07:13PM	Sera Prognostics Inc (SERA) Q4 2024 Earnings Call Transcript (SeekingAlpha) -5.07%
05:20PM	Sera Prognostics, Inc. (SERA) Reports Q4 Loss, Misses Revenue Estimates (Zacks)
04:10PM	SERA PROGNOSTICS ANNOUNCES APPOINTMENT OF JEFF ELLIOTT TO ITS BOARD; RYAN TRIMBLE AND MARCUS WILSON TO STEP DOWN (PR Newswire)
04:05PM	SERA PROGNOSTICS REPORTS FOURTH QUARTER 2024 FINANCIAL RESULTS (PR Newswire)
Mar-11-25 08:30AM	Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2024 Financial Results on March 19, 2025 (PR Newswire)
08:30AM	Loading…
Feb-21-25 08:30AM	Sera Prognostics To Present at TD Cowen 45th Annual Health Care Conference (PR Newswire)
Feb-10-25 10:41PM	Sera Prognostics Announces Pricing of $50 Million Public Offering (PR Newswire) -9.44%
04:01PM	Sera Prognostics Announces Proposed Public Offering (PR Newswire)
Jan-27-25 05:02PM	Sera Prognostics to Host Virtual R&D Day on January 31 (PR Newswire) -5.19%
Jan-06-25 08:30AM	Sera Prognostics to Present at 43rd Annual J.P. Morgan Healthcare Conference (PR Newswire)
Dec-04-24 04:01PM	Sera Prognostics to Present PRIME Study Results at 2025 SMFM Pregnancy Meeting (PR Newswire) +14.78%
Dec-02-24 08:30AM	Sera Prognostics to Present at Piper Sandler 36th Annual Healthcare Conference (PR Newswire)
Nov-26-24 05:00AM	5 investing trends for 2025and 15 stocks to help you bet on them (Fortune)
Nov-15-24 08:30AM	Sera Prognostics to Present at Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum (PR Newswire)
Nov-06-24 06:00PM	Sera Prognostics, Inc. (SERA) Reports Q3 Loss, Lags Revenue Estimates (Zacks) +14.25% -12.70%
04:05PM	SERA PROGNOSTICS REPORTS THIRD QUARTER 2024 FINANCIAL RESULTS (PR Newswire)
Oct-28-24 08:30AM	Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2024 Financial Results on November 6, 2024 (PR Newswire)
Sep-04-24 04:53PM	Sera Prognostics to Present at H.C. Wainwright 26th Annual Global Investment Conference (PR Newswire)
Aug-08-24 08:30AM	Sera Prognostics to Participate in Panel Discussion at UBS Genomic Medicine Summit on August 14, 2024 (PR Newswire)
Aug-07-24 05:50PM	Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Loading…
04:05PM	SERA PROGNOSTICS REPORTS SECOND QUARTER 2024 FINANCIAL RESULTS (PR Newswire)
Jul-25-24 08:30AM	Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2024 Financial Results on August 7, 2024 (PR Newswire)
Jul-09-24 08:30AM	Sera Prognostics PreTRM Test Prevention Strategy Demonstrates 18% Reduction in Severe Neonatal Morbidity and Mortality in Newly Published AVERT Trial (PR Newswire)
Jul-01-24 08:30AM	SERA PROGNOSTICS ADDED TO RUSSELL 2000 AND 3000 INDEXES FOLLOWING CONCLUSION OF 2024 INDEXES ANNUAL RECONSTITUTION (PR Newswire)
Jun-16-24 06:17AM	3 Stocks Under $10 With the Potential to Make You a Millionaire (InvestorPlace)
May-28-24 08:30AM	SERA PROGNOSTICS EXPECTED TO BE ADDED TO RUSSELL 2000 AND 3000 INDEXES (PR Newswire)
May-10-24 03:10PM	Sera Prognostics Inc Reports Q1 2024 Results: A Closer Look at Financials and Strategic Moves (GuruFocus.com) -5.41%
May-09-24 10:44AM	Sera Prognostics, Inc. (NASDAQ:SERA) Q1 2024 Earnings Call Transcript (Insider Monkey) +5.27%
May-08-24 08:57PM	SERA Stock Earnings: Sera Prognostics Beats EPS for Q1 2024 (InvestorPlace)
04:05PM	SERA PROGNOSTICS REPORTS FIRST QUARTER 2024 FINANCIAL RESULTS (PR Newswire)
Apr-29-24 02:15PM	Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2024 Financial Results on May 8, 2024 (PR Newswire)
Mar-29-24 01:32AM	Chief Scientific Officer John Boniface Sells 77,136 Shares of Sera Prognostics Inc (SERA) (GuruFocus.com)
Mar-27-24 01:27AM	Chief Scientific Officer John Boniface Sells 22,163 Shares of Sera Prognostics Inc (SERA) (GuruFocus.com)
Mar-25-24 12:00PM	Sera Prognostics (SERA) Upgraded to Buy: Here's What You Should Know (Zacks) -8.50%
Mar-21-24 09:57AM	Sera Prognostics, Inc. (NASDAQ:SERA) Q4 2023 Earnings Call Transcript (Insider Monkey)
Mar-20-24 08:54PM	SERA Stock Earnings: Sera Prognostics Beats EPS, Misses Revenue for Q4 2023 (InvestorPlace)
05:33PM	Sera Prognostics Inc Reports Modest Revenue Growth Amid Operational Streamlining (GuruFocus.com)
05:20PM	Sera Prognostics, Inc. (SERA) Reports Q4 Loss, Lags Revenue Estimates (Zacks)
04:05PM	SERA PROGNOSTICS REPORTS FOURTH QUARTER 2023 FINANCIAL RESULTS (PR Newswire)
Mar-12-24 11:40AM	25 Countries With Highest Abortion Rates (Insider Monkey)
Mar-04-24 08:30AM	Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2023 Financial Results on March 20, 2024 (PR Newswire)
Feb-29-24 11:14AM	Sera Prognostics To Present at TD Cowen 44th Annual Healthcare Conference (PR Newswire)
Dec-11-23 12:00PM	Here's Why Sera Prognostics, Inc. (SERA) is a Great Momentum Stock to Buy (Zacks)
Dec-06-23 01:19PM	Why Is Sera Prognostics (SERA) Stock Up 260% Today? (InvestorPlace) +161.43%
08:30AM	SERA PROGNOSTICS ANNOUNCES PRIMARY ENDPOINT CRITERIA MET IN PIVOTAL PRIME STUDY INTERIM LOOK - ENROLLMENT TO STOP DUE TO SUCCESS (PR Newswire)
Nov-22-23 01:00PM	SERA PROGNOSTICS TO PRESENT AT 35TH ANNUAL PIPER SANDLER HEALTHCARE CONFERENCE (PR Newswire)
Nov-12-23 10:59AM	Sera Prognostics, Inc. (NASDAQ:SERA) Q3 2023 Earnings Call Transcript (Insider Monkey)
Nov-08-23 06:29PM	Sera Prognostics Inc (SERA) Reports Q3 2023 Financial Results: Revenue Declines as Cost ... (GuruFocus.com) -7.61%
04:05PM	SERA PROGNOSTICS REPORTS THIRD QUARTER 2023 FINANCIAL RESULTS (PR Newswire)
Oct-25-23 08:30AM	Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2023 Financial Results on November 8, 2023 (PR Newswire) +6.06%
Sep-21-23 08:30AM	SERA PROGNOSTICS TO PRESENT AT CANTOR FITZGERALD GLOBAL HEALTHCARE CONFERENCE 2023 (PR Newswire)
Aug-31-23 09:35AM	Sera Prognostics, Inc. (SERA) Loses -32.38% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks) -6.32%
Aug-30-23 09:35AM	Sera Prognostics, Inc. (SERA) Loses -38.49% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Aug-09-23 05:50PM	Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
04:05PM	SERA PROGNOSTICS REPORTS SECOND QUARTER 2023 FINANCIAL RESULTS (PR Newswire)
Jul-31-23 08:30AM	Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2023 Financial Results on August 9, 2023 (PR Newswire)
May-25-23 04:15PM	Sera Prognostics Announces Commercial Changes and Actions to Optimize Business for Market Success Toward Accelerating Test Adoption and Revenue (PR Newswire) -5.08%
May-15-23 05:15PM	Sera Prognostics Announces Retirement of President and CEO Dr. Greg Critchfield and Appointment of Board Member Zhenya Lindgardt as Interim CEO (PR Newswire)
May-10-23 06:05PM	Sera Prognostics, Inc. (SERA) Reports Q1 Loss (Zacks)
04:05PM	SERA PROGNOSTICS REPORTS FIRST QUARTER 2023 FINANCIAL RESULTS (PR Newswire)
May-04-23 07:31AM	We're Not Very Worried About Sera Prognostics' (NASDAQ:SERA) Cash Burn Rate (Simply Wall St.)
Apr-27-23 08:30AM	Sera Prognostics Announces Conference Call and Webcast of First Quarter Fiscal Year 2023 Financial Results on May 10, 2023 (PR Newswire)
Apr-24-23 09:35AM	Sera Prognostics, Inc. (SERA) Loses -13.03% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner (Zacks)
Mar-27-23 12:00PM	All You Need to Know About Sera Prognostics, Inc. (SERA) Rating Upgrade to Buy (Zacks)
02:27AM	Sera Prognostics, Inc. (NASDAQ:SERA) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-24-23 06:29AM	Sera Prognostics Full Year 2022 Earnings: Revenues Miss Expectations (Simply Wall St.)
Mar-22-23 05:35PM	Sera Prognostics, Inc. (SERA) Reports Q4 Loss, Lags Revenue Estimates (Zacks) -6.77%
04:05PM	SERA PROGNOSTICS REPORTS FOURTH QUARTER 2022 FINANCIAL RESULTS (PR Newswire)
Mar-09-23 04:05PM	Sera Prognostics Announces Conference Call and Webcast of Fourth Quarter and Fiscal Year 2022 Financial Results on March 22, 2023 (PR Newswire)
Feb-23-23 04:20PM	SERA PROGNOSTICS TO PRESENT AT UPCOMING MARCH INVESTOR CONFERENCES (PR Newswire) -7.22%
Feb-18-23 07:43AM	Individual investors in Sera Prognostics, Inc. (NASDAQ:SERA) are its biggest bettors, and their bets paid off as stock gained 179% last week (Simply Wall St.)
Feb-15-23 08:30AM	Sera Prognostics Announces Positive Top-line Data from AVERT PRETERM TRIAL (PR Newswire) +73.28%
Nov-29-22 08:30AM	FORS MARSH TO INCLUDE THE PreTRM® TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH SERA PROGNOSTICS (PR Newswire) -7.63%
Nov-15-22 08:30AM	SERA PROGNOSTICS ANNOUNCES PUBLICATION OF DATA PREDICTING CLINICAL UTILITY AND COST EFFECTIVENESS OF THE PRETRM® TEST-AND-TREAT STRATEGY ACROSS DIVERSE POPULATIONS (PR Newswire)
Nov-09-22 06:15PM	Sera Prognostics, Inc. (SERA) Reports Q3 Loss, Tops Revenue Estimates (Zacks) +10.77%
04:05PM	SERA PROGNOSTICS REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS (PR Newswire)
Nov-04-22 04:00PM	Sera Prognostics Announces Conference Call and Webcast of Third Quarter Fiscal Year 2022 Financial Results on November 9 (PR Newswire) -10.37%
Oct-04-22 08:30AM	SONRAVA HEALTH TO INCLUDE THE PreTRM® TEST IN ITS EMPLOYEE MATERNITY BENEFITS PACKAGE IN COLLABORATION WITH CEREBRAE AND SERA PROGNOSTICS (PR Newswire) +7.78%
Sep-22-22 08:30AM	BANNER HEALTH, SERA PROGNOSTICS TEAM UP TO PROVIDE PreTRM® TEST TO COVERED PREGNANT MEMBERS (PR Newswire)
Sep-20-22 07:19AM	Is Sera Prognostics (NASDAQ:SERA) In A Good Position To Invest In Growth? (Simply Wall St.)
Aug-11-22 07:00AM	Sera Prognostics, Inc. (SERA) Q2 2022 Earnings Call Transcript (Motley Fool)
Aug-10-22 05:55PM	Sera Prognostics, Inc. (SERA) Reports Q2 Loss, Lags Revenue Estimates (Zacks) -6.64%
04:05PM	SERA PROGNOSTICS REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS (PR Newswire)
Aug-03-22 10:00AM	Sera Prognostics, Inc. (SERA) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release (Zacks)
Jul-28-22 08:30AM	Sera Prognostics Announces Conference Call and Webcast of Second Quarter Fiscal Year 2022 Financial Results on August 10 (PR Newswire)
Jun-06-22 02:15PM	SERA PROGNOSTICS TO PRESENT AT 42nd ANNUAL WILLIAM BLAIR GROWTH STOCK CONFERENCE (PR Newswire)
May-19-22 04:15PM	SERA PROGNOSTICS ANNOUNCES PUBLICATION OF DATA DEMONSTRATING IMPROVED PERFORMANCE OF ITS PRETRM® TEST WITH MORE PRECISE GESTATIONAL AGE (PR Newswire)
May-18-22 03:03PM	SERA PROGNOSTICS PRESENTS DATA DEMONSTRATING THE HEALTH AND ECONOMIC BENEFIT OF PRETRM® TESTING AT ISPOR ANNUAL MEETING (PR Newswire)
May-10-22 04:05PM	SERA PROGNOSTICS REPORTS FIRST QUARTER 2022 FINANCIAL RESULTS (PR Newswire) -7.11%
May-05-22 08:30AM	SERA PROGNOSTICS AND NEWBORN FOUNDATION PARTNER TO REDUCE RISKS ASSOCIATED WITH PRETERM BIRTH AND IMPROVE HEALTH EQUITY THROUGH THE "EVERY MOTHER, EVERY BABY" PROJECT (PR Newswire)

Sera Prognostics, Inc. engages in the provision of personalized diagnostics to predict and manage pregnancy complications. It focuses on developing blood tests to predict the risks of preterm birth, preeclampsia and other pregnancy complications. The company was founded by Steven W. Graves, Dennis Farrar and M. Sean Esplin in 2008 and is headquartered in Salt Lake City, UT.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Jackson Benjamin	General Counsel	Jun 10 '25	Sale	1.48	965	1,428	134,198	Jun 12 06:54 PM
Boniface John J.	Chief Scientific Officer	Jun 10 '25	Sale	1.48	1,439	2,130	167,982	Jun 12 06:54 PM
Lindgardt Zhenya	Officer	Jun 10 '25	Proposed Sale	1.48	3,344	4,964		Jun 11 08:17 PM
Aerts Austin	Officer	Jun 10 '25	Proposed Sale	1.48	945	1,403		Jun 11 08:17 PM
Lindgardt Zhenya	Officer	Jun 09 '25	Proposed Sale	1.43	23,042	33,042		Jun 11 08:16 PM
Aerts Austin	Officer	Jun 09 '25	Proposed Sale	1.43	5,735	8,224		Jun 11 08:15 PM
Kearney Paul	Officer	Jun 10 '25	Proposed Sale	1.48	1,311	1,946		Jun 11 08:15 PM
Jackson Benjamin	Officer	Jun 10 '25	Proposed Sale	1.48	965	1,433		Jun 11 08:15 PM
Harrison Robert Gardner	Officer	Jun 10 '25	Proposed Sale	1.48	667	990		Jun 11 08:14 PM
Boniface John J.	Officer	Jun 10 '25	Proposed Sale	1.48	1,439	2,136		Jun 11 08:14 PM
Aerts Austin	Chief Financial Officer	Jun 09 '25	Sale	1.43	5,735	8,201	297,593	Jun 11 08:13 PM
Aerts Austin	Chief Financial Officer	Jun 10 '25	Sale	1.48	945	1,399	296,648	Jun 11 08:13 PM
Kearney Paul	Chief Data Officer	Jun 10 '25	Sale	1.48	1,311	1,940	195,400	Jun 11 08:13 PM
Harrison Robert Gardner	Chief Information Officer	Jun 10 '25	Sale	1.48	667	987	114,539	Jun 11 08:12 PM
Lindgardt Zhenya	Chief Executive Officer	Jun 09 '25	Sale	1.43	23,042	32,950	844,209	Jun 11 08:12 PM
Lindgardt Zhenya	Chief Executive Officer	Jun 10 '25	Sale	1.48	3,344	4,949	840,865	Jun 11 08:12 PM
Mirza Mansoor Raza	Director	Jun 06 '25	Proposed Sale	1.58	107	169		Jun 06 06:41 PM
Mirza Mansoor Raza	Director	Jun 06 '25	Sale	1.58	107	169	59,161	Jun 06 06:39 PM
Mirza Mansoor Raza	Director	May 08 '25	Proposed Sale	2.44	106	259		May 09 07:20 PM
Lindgardt Zhenya	Officer	May 08 '25	Proposed Sale	2.44	9,406	22,974		May 09 07:20 PM
Kearney Paul	Officer	May 08 '25	Proposed Sale	2.44	7,089	17,315		May 09 07:20 PM
Jackson Benjamin	Officer	May 08 '25	Proposed Sale	2.44	7,084	17,303		May 09 07:19 PM
Harrison Robert Gardner	Officer	May 08 '25	Proposed Sale	2.44	6,551	16,001		May 09 07:19 PM
Boniface John J.	Officer	May 08 '25	Proposed Sale	2.44	5,132	12,535		May 09 07:19 PM
Aerts Austin	Officer	May 08 '25	Proposed Sale	2.44	6,374	15,569		May 09 07:18 PM
Mirza Mansoor Raza	Director	May 08 '25	Sale	2.44	106	259	43,672	May 09 07:18 PM
Lindgardt Zhenya	Chief Executive Officer	May 08 '25	Sale	2.44	9,406	22,951	867,251	May 09 07:18 PM
Kearney Paul	Chief Data Officer	May 08 '25	Sale	2.44	7,089	17,297	196,711	May 09 07:17 PM
Jackson Benjamin	General Counsel	May 08 '25	Sale	2.44	7,084	17,285	131,460	May 09 07:17 PM
Harrison Robert Gardner	Chief Information Officer	May 08 '25	Sale	2.44	6,551	15,984	115,206	May 09 07:17 PM
Boniface John J.	Chief Scientific Officer	May 08 '25	Sale	2.44	5,132	12,522	165,718	May 09 07:17 PM
Aerts Austin	Chief Financial Officer	May 08 '25	Sale	2.44	6,374	15,553	303,328	May 09 07:16 PM
Mirza Mansoor Raza	Director	Apr 07 '25	Proposed Sale	3.35	107	358		Apr 08 05:21 PM
Mirza Mansoor Raza	Director	Apr 07 '25	Sale	3.35	107	358	43,778	Apr 08 05:21 PM
Lindgardt Zhenya	Officer	Mar 07 '25	Proposed Sale	4.12	29,722	122,529		Mar 10 05:27 PM
Aerts Austin	Officer	Mar 07 '25	Proposed Sale	4.12	4,818	19,862		Mar 10 05:27 PM
Harrison Robert Gardner	Chief Information Officer	Mar 07 '25	Sale	4.16	3,874	16,116	121,757	Mar 10 05:26 PM
Lindgardt Zhenya	Chief Executive Officer	Mar 07 '25	Sale	4.12	29,722	122,455	876,657	Mar 10 05:26 PM
Aerts Austin	Chief Financial Officer	Mar 07 '25	Sale	4.12	4,818	19,850	309,702	Mar 10 05:25 PM
Mirza Mansoor Raza	Director	Mar 06 '25	Proposed Sale	4.16	99	412		Mar 07 07:31 PM
Harrison Robert Gardner	Officer	Mar 06 '25	Proposed Sale	4.16	3,251	13,537		Mar 07 07:31 PM
Kearney Paul	Officer	Mar 06 '25	Proposed Sale	4.16	1,338	5,571		Mar 07 07:31 PM
Jackson Benjamin	Officer	Mar 06 '25	Proposed Sale	4.16	2,285	9,515		Mar 07 07:31 PM
Boniface John J.	Officer	Mar 06 '25	Proposed Sale	4.16	2,044	8,511		Mar 07 07:30 PM
Aerts Austin	Officer	Mar 06 '25	Proposed Sale	4.16	540	2,249		Mar 07 07:30 PM
Mirza Mansoor Raza	Director	Mar 06 '25	Sale	4.16	99	412	43,885	Mar 07 07:30 PM
Kearney Paul	Chief Data Officer	Mar 06 '25	Sale	4.16	1,338	5,566	203,800	Mar 07 07:29 PM
Jackson Benjamin	General Counsel	Mar 06 '25	Sale	4.16	2,285	9,506	138,544	Mar 07 07:29 PM
Harrison Robert Gardner	Chief Information Officer	Mar 06 '25	Sale	4.16	3,251	13,524	125,631	Mar 07 07:29 PM
Boniface John J.	Chief Scientific Officer	Mar 06 '25	Sale	4.16	2,044	8,503	170,850	Mar 07 07:28 PM
Aerts Austin	Chief Financial Officer	Mar 06 '25	Sale	4.16	540	2,246	314,520	Mar 07 07:28 PM
ROBERT G HARRISON	Officer	Mar 07 '25	Proposed Sale	4.15	3,874	16,077		Mar 07 04:19 PM
Harrison Robert Gardner	Chief Information Officer	Feb 13 '25	Sale	4.28	3,610	15,451	103,112	Feb 14 04:17 PM
Mirza Mansoor Raza	Director	Feb 12 '25	Proposed Sale	4.57	101	462		Feb 14 04:16 PM
Lindgardt Zhenya	Officer	Feb 12 '25	Proposed Sale	4.58	14,075	64,404		Feb 14 04:16 PM
Kearney Paul	Officer	Feb 12 '25	Proposed Sale	4.58	5,342	24,444		Feb 14 04:16 PM
Jackson Benjamin	Officer	Feb 12 '25	Proposed Sale	4.58	5,915	27,066		Feb 14 04:15 PM
Harrison Robert Gardner	Officer	Feb 12 '25	Proposed Sale	4.58	7,297	33,390		Feb 14 04:15 PM
Boniface John J.	Officer	Feb 12 '25	Proposed Sale	4.58	5,915	27,066		Feb 14 04:14 PM
Aerts Austin	Officer	Feb 12 '25	Proposed Sale	4.58	5,915	27,066		Feb 14 04:14 PM
Mirza Mansoor Raza	Director	Feb 12 '25	Sale	4.58	101	463	43,984	Feb 14 04:13 PM
Lindgardt Zhenya	Chief Executive Officer	Feb 12 '25	Sale	4.58	14,075	64,464	779,459	Feb 14 04:13 PM
Kearney Paul	Chief Data Officer	Feb 12 '25	Sale	4.58	5,342	24,466	158,128	Feb 14 04:13 PM
Jackson Benjamin	General Counsel	Feb 13 '25	Sale	4.58	5,915	27,091	106,239	Feb 14 04:12 PM
Harrison Robert Gardner	Chief Information Officer	Feb 12 '25	Sale	4.58	7,297	33,420	106,722	Feb 14 04:11 PM
Boniface John J.	Chief Scientific Officer	Feb 12 '25	Sale	4.58	5,915	27,091	125,884	Feb 14 04:11 PM
Aerts Austin	Chief Financial Officer	Feb 12 '25	Sale	4.58	5,915	27,091	277,410	Feb 14 04:10 PM
Harrison Robert Gardner	Chief Information Officer	Feb 11 '25	Sale	3.97	554	2,199	114,019	Feb 13 07:45 PM
ROBERT G HARRISON	Officer	Feb 13 '25	Proposed Sale	4.29	3,610	15,487		Feb 13 04:27 PM
ROBERT HARRISON	Officer	Feb 11 '25	Proposed Sale	4.45	554	2,465		Feb 11 04:33 PM
Mirza Mansoor Raza	Director	Jan 27 '25	Option Exercise	0.91	37,549	34,170	44,085	Jan 27 06:33 PM
Phillips Joshua	Director	Jan 10 '25	Sale	7.40	12,710	94,011	5	Jan 14 09:56 PM
Phillips Joshua	Director	Jan 13 '25	Sale	6.39	12,163	77,722	2	Jan 14 09:56 PM
Phillips Joshua	Director	Jan 14 '25	Sale	6.29	9,338	58,736	0	Jan 14 09:56 PM
Jackson Benjamin	General Counsel	Jan 10 '25	Sale	7.42	13,272	98,531	128,473	Jan 14 09:13 PM
Jackson Benjamin	General Counsel	Jan 14 '25	Sale	6.20	8,407	52,123	112,154	Jan 14 09:13 PM
Jackson Benjamin	General Counsel	Jan 13 '25	Sale	6.38	7,912	50,479	120,561	Jan 14 09:13 PM
Harrison Robert Gardner	Chief Information Officer	Jan 10 '25	Sale	7.39	14,209	105,030	116,837	Jan 14 09:12 PM
Harrison Robert Gardner	Chief Information Officer	Jan 13 '25	Sale	6.47	2,264	14,648	114,573	Jan 14 09:12 PM
Kearney Paul	Chief Data Officer	Jan 10 '25	Sale	7.42	13,419	99,565	163,470	Jan 14 09:11 PM
Aerts Austin	Chief Financial Officer	Jan 10 '25	Sale	8.06	2,431	19,594	283,325	Jan 14 09:11 PM
Catalyst Health Ventures Follo	Shareholder	Jan 10 '25	Proposed Sale	8.32	8	67		Jan 10 05:34 PM
CHV Investments, LLC (Pool 4)	Shareholder	Jan 10 '25	Proposed Sale	8.32	8,562	71,236		Jan 10 05:32 PM
CHV Investments, LLC (Pool 11)	Shareholder	Jan 10 '25	Proposed Sale	8.32	5,320	44,262		Jan 10 05:30 PM
CHV Investments, LLC (Pool 17)	Shareholder	Jan 10 '25	Proposed Sale	8.32	3,232	26,890		Jan 10 05:30 PM
CHV Investments, LLC (Pool 21)	Shareholder	Jan 10 '25	Proposed Sale	8.32	570	4,742		Jan 10 05:29 PM
Catalyst Health Ventures (PF),	Shareholder	Jan 10 '25	Proposed Sale	8.32	9,726	80,920		Jan 10 05:29 PM
CATALYST HEALTH VENTURES LP	Shareholder	Jan 10 '25	Proposed Sale	8.32	6,793	56,518		Jan 10 05:28 PM
AUSTIN AERTS	Officer	Jan 10 '25	Proposed Sale	8.32	20,000	166,400		Jan 10 04:23 PM
PAUL KEARNEY	Officer	Jan 10 '25	Proposed Sale	8.32	52,231	434,562		Jan 10 04:22 PM
ROBERT HARRISON	Officer	Jan 10 '25	Proposed Sale	8.32	16,473	137,055		Jan 10 04:22 PM
BENJAMIN JACKSON	Officer	Jan 10 '25	Proposed Sale	8.32	45,285	376,771		Jan 10 04:21 PM
Mirza Mansoor Raza	Director	Jan 06 '25	Proposed Sale	7.59	100	759		Jan 07 04:05 PM
Mirza Mansoor Raza	Director	Jan 06 '25	Sale	7.69	100	769	6,536	Jan 07 04:05 PM
Lindgardt Zhenya	Officer	Dec 10 '24	Proposed Sale	7.41	26,224	194,396		Dec 12 04:36 PM
Aerts Austin	Officer	Dec 10 '24	Proposed Sale	7.41	5,730	42,476		Dec 12 04:36 PM
Lindgardt Zhenya	Chief Executive Officer	Dec 10 '24	Sale	7.41	26,224	194,320	793,534	Dec 12 04:35 PM
Aerts Austin	Chief Financial Officer	Dec 10 '24	Sale	7.41	5,730	42,459	285,756	Dec 12 04:35 PM
Mirza Mansoor Raza	Director	Dec 06 '24	Sale	7.12	93	662	6,636	Dec 09 04:52 PM
Mirza Mansoor Raza	Director	Dec 06 '24	Proposed Sale	7.12	93	662		Dec 09 04:50 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

SERA

Sera Prognostics Inc

Upgrade your FINVIZ experience